Literature DB >> 19160837

[Comparison of antiviral activity between FeIFN-omega and FeIFN-alpha].

Hongbin Wang1, Xiaojuan Jia, Limin Yang, Lei Sun, Hongning Wang, Wenjun Liu.   

Abstract

Both IFN-omega and IFN-alpha belong to type I interferon and have antiviral, antiproliferative, immunomodulatory activities, but their bioactivities are usually different. FeIFN-omega gene was amplified by PCR. FeIFN-alpha gene was synthesized based on the published sequences of GenBank. Then the two types of feline interferon genes were subcloned into the pET-His vector, and expressed in Escherichia coli Rosetta (DE3). Recombinant interferons were purified by affinity chromatography with immobilized nickel chelating NTA (Ni-NTA) and their antiviral activity was estimated according to the ability of IFNs to inhibit the cytopathic effects (CPE) of virus on cells. Results showed that the antiviral activities against various viruses of FeIFN-omega were higher than those of FeIFN-alpha. Against H9N2 subtype avian influenza virus (AIV) and canine distemper virus (CDV), the antiviral activities of FeIFN-omega were 160 folds and 4 folds higher than those of FeIFN-alpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19160837

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  2 in total

1.  Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats.

Authors:  Philippe R Hennet; Guy A L Camy; David M McGahie; Maxime V Albouy
Journal:  J Feline Med Surg       Date:  2011-08       Impact factor: 2.015

2.  How Behavioral Changes Can Indicate Serious Cerebral Pathology: A Case Report of Concomitant Olfactory Neuroblastoma and Distemper Virus Encephalitis in a Swiss Shepherd Dog.

Authors:  Dario Candini; Ilaria Biasato; Paulo Ricardo Dell'Armelina Rocha; Elena Grego; Maria Teresa Capucchio; Cristina Vercelli
Journal:  Vet Sci       Date:  2017-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.